A rapid pharmacogenomic assay to detect NAT2 polymorphisms and guide isoniazid dosing for tuberculosis treatment
View ORCID ProfileRenu Verma, Sunita Patil, Nan Zhang, View ORCID ProfileFlora M.F. Moreira, Marize T. Vitorio, Andrea da S. Santos, Ellen Wallace, Devasena Gnanashanmugam, David Persing, Rada Savic, Julio Croda, Jason R. Andrews
doi: https://doi.org/10.1101/2021.01.17.21249995
Renu Verma
1Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA
Sunita Patil
1Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA
Nan Zhang
2Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA
Flora M.F. Moreira
3Federal University of Grande Dourados, Dourados, Brazil
Marize T. Vitorio
3Federal University of Grande Dourados, Dourados, Brazil
Andrea da S. Santos
3Federal University of Grande Dourados, Dourados, Brazil
Ellen Wallace
4Cepheid Inc., Sunnyvale, California, USA
Devasena Gnanashanmugam
4Cepheid Inc., Sunnyvale, California, USA
David Persing
4Cepheid Inc., Sunnyvale, California, USA
Rada Savic
2Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA
Julio Croda
5Postgraduate Program in Infectious and Parasitic Diseases, Federal University of Mato Grosso do Sul, Mato Grosso do Sul, Brazil
6Oswaldo Cruz Foundation Mato Grosso do Sul, Mato Grosso do Sul, Brazil
Jason R. Andrews
1Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA
Article usage
Posted March 04, 2021.
A rapid pharmacogenomic assay to detect NAT2 polymorphisms and guide isoniazid dosing for tuberculosis treatment
Renu Verma, Sunita Patil, Nan Zhang, Flora M.F. Moreira, Marize T. Vitorio, Andrea da S. Santos, Ellen Wallace, Devasena Gnanashanmugam, David Persing, Rada Savic, Julio Croda, Jason R. Andrews
medRxiv 2021.01.17.21249995; doi: https://doi.org/10.1101/2021.01.17.21249995
A rapid pharmacogenomic assay to detect NAT2 polymorphisms and guide isoniazid dosing for tuberculosis treatment
Renu Verma, Sunita Patil, Nan Zhang, Flora M.F. Moreira, Marize T. Vitorio, Andrea da S. Santos, Ellen Wallace, Devasena Gnanashanmugam, David Persing, Rada Savic, Julio Croda, Jason R. Andrews
medRxiv 2021.01.17.21249995; doi: https://doi.org/10.1101/2021.01.17.21249995
Subject Area
Subject Areas
- Addiction Medicine (398)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2911)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12693)
- Forensic Medicine (10)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4554)
- Geriatric Medicine (413)
- Health Economics (724)
- Health Informatics (2903)
- Health Policy (1067)
- Hematology (383)
- HIV/AIDS (920)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4320)
- Nursing (233)
- Nutrition (634)
- Oncology (2255)
- Ophthalmology (642)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1194)
- Primary Care Research (493)
- Public and Global Health (6903)
- Radiology and Imaging (1521)
- Respiratory Medicine (913)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)